Your browser doesn't support javascript.
loading
Emerging Biological Functions of IL-17A: A New Target in Chronic Obstructive Pulmonary Disease?
Liu, Meiling; Wu, Kang; Lin, Jinduan; Xie, Qingqiang; Liu, Yuan; Huang, Yin; Zeng, Jun; Yang, Zhaogang; Wang, Yifan; Dong, Shiyan; Deng, Weiye; Yang, Mingming; Wu, Song; Jiang, Wen; Li, Xuefeng.
Afiliação
  • Liu M; The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital; State Key Laboratory of Respiratory Disease, Sino-French Hoffmann Institute, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
  • Wu K; Shenzhen Luohu People's Hospital, The Third Affiliated Hospital of Shenzhen University, Shenzhen, China.
  • Lin J; South China Hospital, Shenzhen University, Shenzhen, China.
  • Xie Q; The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital; State Key Laboratory of Respiratory Disease, Sino-French Hoffmann Institute, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
  • Liu Y; The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital; State Key Laboratory of Respiratory Disease, Sino-French Hoffmann Institute, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
  • Huang Y; The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital; State Key Laboratory of Respiratory Disease, Sino-French Hoffmann Institute, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
  • Zeng J; The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital; State Key Laboratory of Respiratory Disease, Sino-French Hoffmann Institute, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
  • Yang Z; The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital; State Key Laboratory of Respiratory Disease, Sino-French Hoffmann Institute, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
  • Wang Y; Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Dong S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Deng W; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Yang M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Wu S; Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Jiang W; Shenzhen Luohu People's Hospital, The Third Affiliated Hospital of Shenzhen University, Shenzhen, China.
  • Li X; South China Hospital, Shenzhen University, Shenzhen, China.
Front Pharmacol ; 12: 695957, 2021.
Article em En | MEDLINE | ID: mdl-34305606

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China